Showing results (41-50 of 61) with videos related to
Sort By:
Pageof 7
Journal of the American Medical Informatics Association : JAMIA|August 28, 2013
Development and use of active clinical decision support for preemptive pharmacogenomicsGillian C Bell, Kristine R Crews, Mark R Wilkinson, et al.Cancer Research|January 29, 2014
ATDC/TRIM29 phosphorylation by ATM/MAPKAP kinase 2 mediates radioresistance in pancreatic cancer cellsLidong Wang, Huibin Yang, Phillip L Palmbos, et al.Clinical Pharmacology and Therapeutics|September 25, 2019
Prospective CYP2C19-Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma ConcentrationsJ Kevin Hicks, Rod E Quilitz, Rami S Komrokji, et al.Clinical and Translational Science|December 28, 2025
Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine TherapyNihal El Rouby, Christina L Aquilante, Salma A Bargal, et al.Contemporary Clinical Trials|March 15, 2018
Design and rational for the precision medicine guided treatment for cancer pain pragmatic clinical trialScott A Mosley, J Kevin Hicks, Diane G Portman, et al.JCO Precision Oncology|July 9, 2025
Germline POT1 Variants in a Pan-Cancer CohortPamela L Brock, Morgan Webster, Sandya Liyanarachchi, et al.Clinical Pharmacology and Therapeutics|April 9, 2023
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor AntidepressantsChad A Bousman, James M Stevenson, Laura B Ramsey, et al.Pharmacotherapy|September 12, 2023
CYP2D6-guided opioid therapy for adults with cancer pain: A randomized implementation clinical trialScott A Mosley, Emily Cicali, Alex Del Cueto, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 20, 2021
Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testingJulio D Duarte, Rachel Dalton, Amanda L Elchynski, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2018
Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLCXiuning Le, Sonam Puri, Marcelo V Negrao, et al.Pageof 7